IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科
学科主题临床医学
QUANTITATIVE HEPATITIS B CORE ANTIBODY LEVEL IS A NEW BASELINE PREDICTOR FOR TREATMENT RESPONSE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING PEGINTERFERON THERAPY
Wang, G. -Q.1,2; Hou, F. -Q.1,2; Song, L. -W.3,4; Xia, N. -S.3,4; Yuan, Q.3,4; Fang, L. -L.3,4; Ge, S. -X.3,4; Zhang, J.3,4; Sun, L.5; Sheng, J. -F.6; Xie, D. -Y.7; Shang, J.8; Wu, S. -H.9; Sun, Y. -T.10; Wei, S. -F.11
刊名JOURNAL OF HEPATOLOGY
2014-04-01
suppl.S期:1页:S439-S439
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Gastroenterology & Hepatology
研究领域[WOS]Gastroenterology & Hepatology
语种英语
WOS记录号WOS:000362828600502
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59161
Collection北京大学第一临床医学院_感染疾病科
作者单位1.Peking Univ, Dept Infect Dis, Hosp 1, Beijing 100871, Peoples R China
2.Peking Univ, Ctr Liver Dis, Hosp 1, Beijing 100871, Peoples R China
3.Xiamen Univ, Sch Publ Hlth, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China
4.Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China
5.Xiamen Amoytop Biotech Co Ltd, Xiamen, Peoples R China
6.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China
7.Sun Yet Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China
8.Henan Prov Peoples Hosp, Dept Infect Dis, Zhengzhou, Peoples R China
9.Zhengzhou Univ, Affiliated Hosp 1, Dept Infect Dis, Zhengzhou 450052, Peoples R China
10.Forth Mil Med Univ, Tang Du Hosp, Dept Infect Dis, Xian, Peoples R China
11.Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Peoples R China
Recommended Citation
GB/T 7714
Wang, G. -Q.,Hou, F. -Q.,Song, L. -W.,et al. QUANTITATIVE HEPATITIS B CORE ANTIBODY LEVEL IS A NEW BASELINE PREDICTOR FOR TREATMENT RESPONSE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING PEGINTERFERON THERAPY[J]. JOURNAL OF HEPATOLOGY,2014,suppl.S(1):S439-S439.
APA Wang, G. -Q..,Hou, F. -Q..,Song, L. -W..,Xia, N. -S..,Yuan, Q..,...&Wei, S. -F..(2014).QUANTITATIVE HEPATITIS B CORE ANTIBODY LEVEL IS A NEW BASELINE PREDICTOR FOR TREATMENT RESPONSE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING PEGINTERFERON THERAPY.JOURNAL OF HEPATOLOGY,suppl.S(1),S439-S439.
MLA Wang, G. -Q.,et al."QUANTITATIVE HEPATITIS B CORE ANTIBODY LEVEL IS A NEW BASELINE PREDICTOR FOR TREATMENT RESPONSE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING PEGINTERFERON THERAPY".JOURNAL OF HEPATOLOGY suppl.S.1(2014):S439-S439.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Wang, G. -Q.]'s Articles
[Hou, F. -Q.]'s Articles
[Song, L. -W.]'s Articles
百度学术
百度学术Similar articles in
[Wang, G. -Q.]'s Articles
[Hou, F. -Q.]'s Articles
[Song, L. -W.]'s Articles
必应学术
必应学术Similar articles in
[Wang, G. -Q.]'s Articles
[Hou, F. -Q.]'s Articles
[Song, L. -W.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.